Research progress of measurement tools for health-related quality of life in patients with spinal metastases
10.3760/cma.j.cn121113-20230317-00141
- VernacularTitle:脊柱转移瘤患者健康相关生活质量测量工具的研究进展
- Author:
Mengchen YIN
1
;
Wenlong YU
;
Lin LI
;
Xin GAO
;
Luosheng ZHANG
;
Dingbang CHEN
;
Quan HUANG
;
Xinghai YANG
;
Junming MA
;
Jianru XIAO
;
Wen MO
Author Information
1. 上海中医药大学附属龙华医院骨伤科，上海 200032
- Keywords:
Spine;
Neoplasm metastasis;
Quality of life;
Measurement tools
- From:
Chinese Journal of Orthopaedics
2023;43(16):1115-1122
- CountryChina
- Language:Chinese
-
Abstract:
The Health-Related Quality of Life (HRQoL) pertains to patients' subjective contentment concerning their physical, psychological, and social well-being throughout disease treatments. Predominantly employed HRQoL metrics in spinal metastases comprise the 36-item Short-Form Health Survey (SF-36), EuroQoL Five Dimensions Questionnaire (EQ-5D), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30), and the Functional Assessment of Cancer Therapy-General (FACT-G). In clinical applications, due to their broad application and diverse disease types, combined with the lack of specificity in the scale content and the prolixity of their questionnaires, these tools often fail to capture the nuanced experiences of patients, thereby compromising the reliability and validity of the results. The Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ), developed by the Spine Oncology Study Group, offers a tailored metric for spinal metastases, encapsulating both specificity and inclusivity. Its proven robust reliability and validity make it invaluable for decision-making and therapeutic efficacy appraisals. The Patient-Reported Outcome Measurement Information System (PROMIS), a novel metric suitable across many medical disciplines, facilitates cross-sector data acquisition, substantially augmenting the precision, sensitivity, and credibilityof assessments, and is pivotal in clinical investigations and interventions. As it continually evolves, PROMIS consistently outperforms traditional metrics in evaluative capacities, exhibiting impressive and consistent proficiency in prognostications, preoperative assessments, and therapeutic outcome evaluations within the spinal metastasis domain. Presently, Chinese research on the HRQoL of spinal metastasis patients remains scant, and choosing an apt, precise, and dependable metric holds significant clinical relevance. Drawing upon extant scholarly publications, this review concluded the current global HRQoL tools for spinal metastases, aiming to furnish insights for the clinical management and research pertaining to spinal metastases.
